AIDS researchers have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases. The study, published today in PLoS ONE, demonstrates that human stem cells can be engineered into the equivalent of a genetic vaccine.
By Taking CD8 cytotoxic T lymphocytes — the "killer" T cells that help fight infection — from an HIV-infected individual, the researchers identified the molecule known as the T-cell receptor, which guides the T cell in recognizing and killing HIV-infected cells.
These cells, while able to destroy HIV-infected cells, do not exist in enough quantities to clear the virus from the body. So the researchers cloned the receptor and genetically engineered human blood stem cells, then placed the stem cells into human thymus tissue that had been implanted in mice, allowing them to study the reaction in a living organism.
The engineered stem cells developed into a large population of mature, multifunctional HIV-specific CD8 cells that could specifically target cells containing HIV proteins. The researchers also found that HIV-specific T-cell receptors have to be matched to an individual in much the same way that an organ is matched to a transplant patient.
"We have demonstrated in this proof-of-principle study that this type of approach can be used to engineer the human immune system, particularly the T-cell response, to specifically target HIV-infected cells," said lead investigator Scott G. Kitchen, assistant professor of medicine in the division of hematology and oncology at UCLA.
"These studies lay the foundation for further therapeutic development that involves restoring damaged or defective immune responses toward a variety of viruses that cause chronic disease, or even different types of tumors."
The next step is to test this strategy in a more advanced model to determine if it would work in the human body, said co-author Jerome A. Zack, UCLA professor of medicine in the division of hematology and oncology and associate director of the UCLA AIDS Institute. The researchers also hope to expand the range of viruses against which this approach could be used.
Citation: Kitchen SG, Bennett M, Galić Z, Kim J, Xu Q, et al., 'Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice', PLoS ONE 2009, 4(12): e8208. doi:10.1371/journal.pone.0008208
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Gravitational Waves? Watch the LIGO press conference at 10:30 Eastern.
- LIGO, Gravitational Waves, And Laser Interferometry
- Giddings: The 750 GeV Diphoton Resonance Is A Graviton
- The Greenhouse Effect Fallacy
- Starting Age Of Marijuana Use May Have Long-term Effects On Brain Development
- Native Grass Make Super-Thin Condoms
- Lipid-based Diets Effectively Combat Alzheimer's Disease In Mouse Model
- "After promising 'transparency', Obama has gone down a road of (probably unconstitutional unilateralism)..."
- "Yes the details of the gravitational waves they detect will be very important. Will they..."
- "For what its worth (and at this point, it is worth nothing), my space-times-time invariance as..."
- "Here's a link to the twins study: http://news.meta.com/2016/01/18/twinsstudy/..."
- "Marijuana creates a greater degree of grey matter in the brain. it is the most important human..."
- Increasing BRCA testing rates in young women with breast cancer
- The sleeping giant
- New test could help select the best treatment for bowel cancer patients
- Cornell astrophysicists play vital role to validate detection of gravitational waves
- Daily dose of beetroot juice improved endurance and blood pressure